Sign in
4/A

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-035852

Options or other derivatives

  • Chief Business Officer acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sniecinski Megan · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-17 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +240,000 240,000 D
Loading xslF345X03/form4a.xml…